Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...
The S&P 500 just delivered its best January-through-September performance since 1997 and has now entered the third year of ...
It is a tight race, but there is increasing talk late week that the stock market is pricing in a Trump victory ... As a result, oil and gas futures plummeted. Crude oil prices dropped over $6.00 per ...
As you can see, revenue growth dropped to just 1% in 2022's Q4, but if you had bought the stock then, you'd be up more than ...
The company has long been known as a stodgy passive-income powerhouse. But the last few years have been challenging, as ...